相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial
Giovanni Abbruzzese et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients
Carlo Cattaneo et al.
JOURNAL OF PARKINSONS DISEASE (2020)
The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review
Brian A. Baldo et al.
BRITISH JOURNAL OF ANAESTHESIA (2020)
Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study
Nobutaka Hattori et al.
PARKINSONISM & RELATED DISORDERS (2020)
Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study
Yoshio Tsuboi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide
Sebastian Schade et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2020)
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside
Marika Alborghetti et al.
CURRENT NEUROPHARMACOLOGY (2019)
Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study
Gloria Marti-Andres et al.
BRAIN SCIENCES (2019)
Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease
Maria Laura Ester Bianchi et al.
NEUROLOGICAL SCIENCES (2019)
Real life evaluation of safinamide effectiveness in Parkinson's disease
Francesca Mancini et al.
NEUROLOGICAL SCIENCES (2018)
Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease
Carlo Cattaneo et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations A Randomized Clinical Trial
Anthony H. V. Schapira et al.
JAMA NEUROLOGY (2017)
Adjuvant therapies for Parkinson's disease: critical evaluation of safinamide
Fabrizio Stocchi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Depression rating scales in Parkinson's disease: A critical review updating recent literature
Elizabeth Torbey et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study Effects on Nonmotor Symptoms and Tolerability
Kara M. Smith et al.
JAMA NEUROLOGY (2015)
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
Rupam Borgohain et al.
MOVEMENT DISORDERS (2014)
Two-Year, Randomized, Controlled Study of Safinamide as Add-on to Levodopa in Mid to Late Parkinson's Disease
Rupam Borgohain et al.
MOVEMENT DISORDERS (2014)
Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
Michel Panisset et al.
PHARMACOTHERAPY (2014)
Combined Beneficial Effect of Rasagiline on Motor Function and Depression in De Novo PD
Alexei Korchounov et al.
CLINICAL NEUROPHARMACOLOGY (2012)
A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients
Fabrizio Stocchi et al.
MOVEMENT DISORDERS (2012)
Depression in Parkinson disease-epidemiology, mechanisms and management
Dag Aarsland et al.
NATURE REVIEWS NEUROLOGY (2012)
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Paolo Barone et al.
LANCET NEUROLOGY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Glutamatergic Modulators: The Future of Treating Mood Disorders?
Carlos Zarate et al.
HARVARD REVIEW OF PSYCHIATRY (2010)
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
Rodrigo Machado-Vieira et al.
NEUROSCIENTIST (2009)
Effects of Ropinirole on Nonmotor Symptoms of Parkinson Disease: A Prospective Multicenter Study
Irena Rektorova et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Anxiety and depression: Main determinants of health-related quality of life in Brazilian patients with Parkinson's disease
Francisco Javier Carod-Artal et al.
PARKINSONISM & RELATED DISORDERS (2008)
分享论文
